Selected article for: "CE chronic enteropathy and chronic enteropathy"
Title: Research Communications of the 24th ECVIM-CA Congress
  • Document date: 2015_1_10
    • ID: r59usk02_405
    Snippet: The author works at Texas A&M University, whose GI Lab currently offer a commercial assay for faecal Alpha1-Proteinase Inhibitor. Canine chronic enteropathy (CE) is a common, but poorly understood syndrome, with variable response to therapy and prognosis. There is a need for novel biomarkers that are specific for intestinal disease and that provide objective measures of disease severity, progression, and prognosis. Serum citrulline is a useful bi.....
    Document: The author works at Texas A&M University, whose GI Lab currently offer a commercial assay for faecal Alpha1-Proteinase Inhibitor. Canine chronic enteropathy (CE) is a common, but poorly understood syndrome, with variable response to therapy and prognosis. There is a need for novel biomarkers that are specific for intestinal disease and that provide objective measures of disease severity, progression, and prognosis. Serum citrulline is a useful biomarker in human intestinal disease as it is specific to the small intestine and indicates globally reduced enterocyte mass and absorptive function in various disease states. It is used to determine, quantitatively, intestinal integrity at the enterocyte level and is not influenced by nutritional or inflammatory status. The aim of this study was to determine whether serum citrulline can be used as a biomarker for CE in dogs.

    Search related documents:
    Co phrase search for related documents
    • canine chronic enteropathy and CE canine chronic enteropathy: 1, 2, 3
    • canine chronic enteropathy and chronic enteropathy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • canine chronic enteropathy and disease severity: 1, 2, 3, 4
    • CE canine chronic enteropathy and chronic enteropathy: 1, 2, 3
    • chronic enteropathy and disease severity: 1, 2, 3, 4, 5, 6
    • commercial assay and disease severity: 1, 2, 3, 4
    • disease severity and inflammatory nutritional status: 1